MedPath

Study to look for better and cost effective localizing material in patients with breast cancer under going neoadjuvant chemotherapy followed by breast conservation surgery.

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/02/031233
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Locally advanced breast cancer patients suitable for breast conservation.

2.Partial response with more than 30% reduction of tumour size in longest diameter after two cycles of neoadjuvant.

3.Any triple negative breast cancer planned for NACT.

Exclusion Criteria

1.Breast tumor with widespread skin involvement.

2.Inflammatory and metastatic breast cancers.

3.Contraindication for Radiotherapy.

4.Patients who denied consent

5.Male breast cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath